Huatai Peptide Retatrutide
As of 9 Aug 2026, Finnrick has published 8 independent lab tests of Retatrutide from Huatai Peptide: 2 passed and 6 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 30 Jul 2026. The current Finnrick rating for Huatai Peptide Retatrutide is 61%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 30 Jul 2026 | Pass | Certificate 2687jku |
| 3 Mar 2026 | Fail | Certificate g4wu7xy |
| 26 Feb 2026 | Fail | Certificate tbuua7y |
| 26 Feb 2026 | Fail | Certificate 5erphhy |
| 22 Feb 2026 | Fail | Certificate ejshqt8 |
| 18 Feb 2026 | Pass | Certificate qzey24u |
| 7 Jan 2026 | Fail | Certificate vyhmypj |
| 7 Jan 2026 | Fail | Certificate a577n2y |